Using Illegal Propofol, Ga In Brown Eyed Girls Fined Rp 12 Million

Eka P
0

The public was recently shocked by the news that a top Korean girl group member was fined for being caught using propofol illegally. His figure was finally revealed.

korean celeb gossip, korean celebrities latest news, korean celebrities gossip, korean celebrity gossip news, korean star news daily, korean actor gossip, korean celeb gossip quora

It is known, propofol is a drug that cannot be bought carelessly, and must use a doctor's prescription. The girl group member in question reportedly got the drug through a plastic surgeon in his 70s and claimed the drug was used as a treatment.

After getting news from a trusted source, the police immediately went to the residence of the girl group member who was eventually known as Ga In Brown Eyed Girls. After a search of his home, the police found propofol and a number of other illegal drugs.

After conducting a long investigation, Ga In was fined after admitting to this incident in early 2021, he also admitted to using propofol from July to August 2019. He was fined 1 million Won or around Rp. 12 million.

Ga In admitted to having insomnia and depression so she used these drugs. Meanwhile, the plastic surgeon who illegally gave drugs to Ga In was sentenced to 1.5 years in prison for violating pharmaceutical law.

Shortly after the news was revealed, Mystic Story as management gave a statement. In the statement, it apologized for what had happened.

"Although Ga In and management realized this incident was not true, at that time we did not apologize. So at this time we want to apologize for worrying," said management.

"During activities, Ga In suffered a number of injuries. He had suffered from pain, depression, and insomnia for a long time. Therefore, he made a reckless decision," he explained.

At the end of the statement, Ga In and management promised to prevent the same thing from happening again. He promised to show a better image in front of the public and fans. /hot.detik.com

Post a Comment

0Comments

Post a Comment (0)